论文部分内容阅读
报告51例Banett食管癌的外科治疗效果,占同期食管癌切除总数的10.2%。患者平均年龄8岁,主要就诊症状为吞咽困难。按PTNM分期,Ⅱ期18例,占35.3%;Ⅲ期29例,占56.9%;Ⅳ期4例,占7.8%。51例均行食管部分切除、胃食管重建术。术后30天死亡率为3.9%,1、2和5年生存率分别为45.9%、25.0%和13.6%。Ⅱ期肿瘤5年生存率(25.0%)明显高于Ⅲ+Ⅳ期(4.5%),两者差异有显著意义(P<0.05)。肿瘤直径<6cm<或>6cm者,5年生存率分别为25.0%和0(P<0.05)。结果表明,术后长期生存率与临床分期及肿瘤大小等因素有密切关系。
The surgical treatment of 51 cases of Banett cancers was reported, accounting for 10.2% of the total number of esophageal cancers removed at the same time. The average age of the patients was 8 years old and the main symptom was dysphagia. According to PTNM stage, 18 cases were in stage II, accounting for 35.3%; 29 cases were in stage III, accounting for 56.9%; 4 cases were in stage IV, accounting for 7.8%. All the 51 patients underwent partial esophageal resection and gastroesophageal reconstruction. The 30-day mortality rate was 3.9%, and the 1-, 2-, and 5-year survival rates were 45.9%, 25.0%, and 13.6%, respectively. The 5-year survival rate of stage II tumors (25.0%) was significantly higher than that of stage III+IV (4.5%), and there was a significant difference between them (P<0.05). For patients with tumor diameter <6cm 6cm, 5-year survival rates were 25.0% and 0, respectively (P < 0.05). The results showed that long-term survival after surgery was closely related to factors such as clinical stage and tumor size.